Pediatric cancers in Tunisia: Epidemiology, clinical characteristics and survival outcomes from a 10-year single-center experience
DOI:
https://doi.org/10.62438/tunismed.v104i05.6685Keywords:
pediatric cancer, net survival, epidemiology, prognostic factors, Tunisia, low- and middle-income countriesAbstract
Background and aims: Pediatric cancers represent a major public health challenge, particularly in low- and middle-income countries (LMICs). This study aimed to describe the epidemiological and clinical characteristics of pediatric cancers managed at a reference center in Tunisia, analyze treatment pathways, and identify prognostic factors associated with net survival.
Methods: A retrospective, single-center, observational prognostic study was conducted at the Pediatric Oncology Unit (POU) of Béchir Hamza Children's Hospital of Tunis over ten years (January 2012 – December 2021), in accordance with STROBE guidelines. All children diagnosed with cancer before age 16 years were included.
Results: A total of 563 children were included (sex ratio 1.18). Mean age at diagnosis was 4.3 ± 3.8 years (median: 3.0 years). Solid tumors predominated (81%), led by neuroblastoma (23.6%), renal tumors (17.2%), and retinoblastoma (10.7%). Five-year net survival was 69%. Multivariate Cox regression identified four independent prognostic factors: leukemia (HR=3.33, 95% CI: 2.07–5.35, p<0.001), metastatic disease (HR=2.65, 95% CI: 1.92–3.66, p<0.001), relapse (HR=2.74, 95% CI: 1.96–3.82, p<0.001), and residence >100 km from the POU (HR=1.32, 95% CI: 0.97–1.80, p=0.018).
Conclusions: Satisfactory survival outcomes are achievable in resource-limited settings with a well-structured oncology unit. Reducing geographic barriers to care and strengthening early diagnosis remain key priorities to further improve outcomes.
Downloads
References
Lam CG, Howard SC, Bouffet E, Pritchard-Jones K. Science and health for all children with cancer. Science. 2019;363(6432):1182-6.
Huang J, Chan SC, Ngai CH, Lok V, Zhang L, Lucero-Prisno DE, et al. Global incidence, mortality and temporal trends of cancer in
children: a joinpoint regression analysis. Cancer Med [Internet]. 2022 Jul [cited 2022 Nov 24]. Available from: https://onlinelibrary.
wiley.com/doi/pdf/10.1002/cam4.5009
Johnston WT, Erdmann F, Newton R, Steliarova-Foucher E, Schüz J, Roman E. Childhood cancer: estimating regional and global incidence. Cancer Epidemiol. 2021;71:101662.
Ministère de la Santé Publique (Tunisie). Registre des cancers du Nord de la Tunisie : données 2010–2014. Tunis: Ministère de la
Santé Publique; 2021.
Missaoui N, Khouzemi M, Landolsi H, Jaidene L, Abdelkrim SB, Abdelkader AB, et al. Childhood cancer frequency in the center of
Tunisia. Asian Pac J Cancer Prev. 2011;12(2):537-42.
Steliarova-Foucher E, Colombet M, Ries LAG, Moreno F, Dolya A, Bray F, et al. International incidence of childhood cancer, 2001–10:
a population-based registry study. Lancet Oncol. 2017;18(6):719-31.
Kerber RA, O’Brien E. A cohort study of cancer risk in relation to family histories of cancer in the Utah population database. Cancer.
;103(9):1906-15.
Fragkandrea I, Nixon JA, Panagopoulou P. Signs and symptoms of childhood cancer: a guide for early recognition. Am Fam Physician.
;88(3):185-92.
Brasme JF, Morfouace M, Grill J, Martinot A, Amalberti R, Bons- Letouzey C, et al. Delays in diagnosis of paediatric cancers: a
systematic review. Lancet Oncol. 2012;13(10):445-59.
Heaton TE, Davidoff AM. Surgical treatment of pulmonary metastases in pediatric solid tumors. Semin Pediatr Surg.2016;25(5):311-7.
Ward ZJ, Yeh JM, Bhakta N, Frazier AL, Girardi F, Atun R. Global childhood cancer survival estimates and priority-setting. Lancet
Oncol. 2019;20(7):972-83.
Dahbi I, Hessissen L, Khatab M, Ahid S, Assarag B, Belalia A, et al. Childhood cancer survival rate and characteristics in Morocco: a
retrospective cohort study [Internet]. 2019 Oct [cited 2022 Nov21]. Available from: https://www.tephinet.org/learning/fead/
childhood-cancer-survival-rate-and-characteristics-in-morocco-a- retrospective-cohort
Soliman RM, Elhaddad A, Oke J, Eweida W, Sidhom I, Ahmed S, et al. Temporal trends in childhood cancer survival in Egypt, 2007–2017.
Int J Cancer. 2021;148(7):1562-74.
Togo B, Traoré F, Togo AP, Togo P, Diakité AA, Traoré B, et al. Epidemiology and prognosis of childhood cancers in Mali. Med
Sante Trop. 2014;24(1):68-72.
Edgar AB, Borthwick S, Duffin K, Marciniak-Stepak P, Wallace WH. Re-engaging childhood cancer survivors lost to follow-up. Eur J
Cancer. 2012;48(7):1066-73.
Tuina HN. Les cancers de l’enfant aux CHU Yalgado Ouédraogo et Charles de Gaulle [thesis]. Ouagadougou: Université de
Ouagadougou; 2013.
Joko-Fru WY, Parkin DM, Borok M, Chokunonga E, Korir A, Nambooze S, et al. Survival from childhood cancers in eastern
Africa. Int J Cancer. 2018;143(10):2409-15.
Lacour B, Goujon S, Guissou S, Guyot-Goubin A, Desmée S, Désandes E, et al. Childhood cancer survival in France, 2000–2008.
Eur J Cancer Prev. 2014;23(5):449-57.
Bourusly MJ, BurahmaMH, Khalifa N,MottiH, Kaleefa S, Adil M, et al. Trends in childhood cancer in Kuwait. Cureus. 2021;13(2):e13333.
Wasilewski Masker K, Liu Q, Yasui Y, Leisenring W, Meacham LR, Hammond S, et al. Late recurrence in pediatric cancer: a report
from the childhood cancer survivor study. J Natl Cancer Inst. 2009 Dec;101(24):1709-20.
Additional Files
Published
License
Copyright (c) 2026 La Tunisie Médicale
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
